Fingerprint
Dive into the research topics of 'Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group protocol S9911'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically